Associated Papers
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories.
Borate U et al.
Blood Advances, 2023
Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms.
Maze D et al.
Ejhaem, 2023
Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform.
Lee P et al.
International Journal of Molecular Sciences, 2022
TET2 Variants in Japanese Patients With Pulmonary Arterial Hypertension.
Hiraide T et al.
Cjc Open, 2022
Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
Wu X et al.
Bmc Cancer, 2022
Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.
Yu H et al.
Frontiers in Oncology, 2022
TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan.
Shaikh ARK et al.
Peerj, 2021
Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq.
Gao J et al.
International Journal of Molecular Sciences, 2020
TET2 missense variants in human neoplasia. A proposal of structural and functional classification.
Bussaglia E et al.
Molecular Genetics & Genomic Medicine, 2019
Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.
Lee JW et al.
Plos One, 2019
Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
Lyu Y et al.
Leukemia, 2017
Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
Lin TL et al.
Haematologica, 2014
Feature-based classification of amino acid substitutions outside conserved functional protein domains.
Gemovic B et al.
Thescientificworldjournal, 2013
[Pedigree investigation of clinicopathologic features and alpha-galactosidase A gene mutation in a family with Fabry disease].
Liu XX et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition, 2012
[Investigation of family pedigree rare blood group of JK(a-b-) phenotype].
Gong TX et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2012
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Chou WC et al.
Blood, 2011
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhu JF et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2011
[Mutation of tet2 gene and malignant blood disease].
Qian XF et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2010
[Report of gene mutation hot spots analysis in one congenital cataract pedigree].
Zhang X et al.
Yan Ke Xue Bao = Eye Science, 2004
Adult Acute Myeloid Leukemia with the KMT2A-Mixed Lineage Leukemia T10 Fusion: An Analysis of 10 Cases Showed Common Features and Frequent Mutations in the RAS Signaling Pathway.
Cai X et al.
Acta Haematologica, 0